HOME | 中文 | ENGLISH
Home
About Us
Wuxi Beita
Changsha Beita
Cooperation Units
Intellectual Property
Academic Publications
Qualification
Products
Radioisotope Labeled Products
Stable Isotope Labeled Products
Services
Technology Advantages
Labeling Service
Detection and Analysis Services
Customers
News
Beita News
Industry News
Media Coverage
Contact Us
Feedback
Information List
Wuxi Beta conquers the key technology of isotope labeling to help new drug research and development-Xinhua-Jiangsu Channel.
2019-04-15
Wuxi Beta Conquers Key Technology of Isotope Labeling to Help New Drug Research and Development March 21, 2019 11:10:13 Source: Wuxi Beta Pharmaceutical Technology Co., Ltd. Website: http://www.js.xinhuanet.com/2019-03/21/c_1124263801.htm近日,位于江苏江阴高新区的无锡贝塔医药科技有限公司与四川科伦药物研究院签订科技服务合作协议 。 The head of the hospital's new drug research and development department recognized Wuxi Beta's radioisotope labeling work and believed that Wuxi Beta 2
Wuxi Beta Conquers Key Technology of Isotope Labeling to Help New Drug Research and Development-Torch Center of Ministry of Science and Technology
Jiangyin High-tech Zone: Wuxi Beta Conquers Key Technology of Isotope Labeling to Help New Drug Research and Development March 26, 2019 Source: China High-tech Industry Herald Website: http://www.ctp.gov.cn/kjb/dfdt/201903/bde017961f1044aa833792f9e823ef02.shtml近日获悉,江阴高新区企业无锡贝塔医药科技有限公司与四川科伦药物研究院签订科技服务合作协议 。 The new drug research and development department of Sichuan Kelun Pharmaceutical Research Institute is negative.
Overcome the technical difficulties in the preparation of carbon -14 labeled key compounds-the website of the Chinese Academy of Sciences.
Technical Difficulties in Preparation of Carbon -14 Marked Key Compounds Overcome Time: 2019-03-2223:36 Author: Unknown Source: Unknown Click: 875 Times Website: http://guoshizhong.com/huaxuekexue/2019/0322/18856.html科江阴3月20日电3月20日,江苏省江阴国家高新区发布了一项重点创新成果:该区无锡贝塔医药科技有限公司研发团队经过10年努力,攻克了碳-14标记关键化合物制备和标记技术难关,
Carbon -14 Marked Key Compound Preparation Technology Difficulties Overcome-Third Edition-Science and Technology Daily
Technical Difficulties in Preparation of Carbon -14 Labeled Key Compounds Overcome 2019-03-2100:00:00 Source: Science and Technology Daily Author: Reporter Guo Guozhong Science and Technology Daily Jiangyin, March 20 (Reporter Guo Guozhong Correspondent Shen Wei Guo Yin Qingxi) On March 20, Jiangyin National High-tech Zone in Jiangsu Province released a key innovation: After 10 years of hard work, the research and development team of Wuxi Beta Pharmaceutical Technology Co., Ltd. in the zone, overcoming the technical difficulties in the preparation and labeling of key compounds labeled with carbon -14, and integrating the application of a number of modern advanced technologies, we have successfully developed a technology for the treatment of gastric cancer.
Xi Jinping: Accelerate the in-depth development of military-civilian integration
2018-10-15
China Government Network 2018-10-15 Source: Xinhua News Agency Xi Jinping presided over the second meeting of the Central Military-civilian Integration Development Committee, emphasizing the strengthening of responsibility, implementation, and accelerating the in-depth development of military-civilian integration. Wang Huning and Han Zheng attended the General Secretary of the CPC Central Committee, President of the State, Chairman of the Central Military Commission, and Director of the Central Military-civilian Integration Development Committee Xi Jinping presided over the second meeting of the Central Military-civilian Integration Development Committee on October 15th and delivered an important speech. The meeting considered and adopted the opinions on strengthening the construction of the rule of law in the development of military and civilian integration. Xi Jinping stressed that we should strengthen responsibility, pay close attention to implementation and improve the rule of law.
The State Council Releases "Double Creation" Upgrade Opinions: Supporting the Listing of Innovative Enterprises That have Not Yet Profitable
2018-09-26
Abstract: when the reform of the Association for Science and Technology is in progress, it was reported on September 26, 2018 that the State Council's opinions on promoting the high-quality development of innovation and entrepreneurship and creating an upgraded version of "mass entrepreneurship and innovation" (Guofa [2018] No. 32), including increasing support for "specialized, special and new" small and medium-sized enterprises, encouraging small and medium-sized enterprises to participate in the research and development of key common technologies in the industry, continuously improving the innovation ability of enterprises, and cultivate innovative ability, support innovative enterprises with good development potential but not yet profitable to be listed or listed on the new three boards and regional equity markets. Technology companies are allowed to implement a "same share with different rights" governance structure, and so on. Tools
Draft for Soliciting Comments on the People's Republic of China Atomic Energy Law
2018-09-21
Abstract: Xinhua News Agency, Beijing, September 21, 2018. The Ministry of Justice announced the "the People's Republic of China Atomic Energy Law (Draft for Comment)" on the 21st to solicit public opinions. These include: strengthening the scientific research and technology development of atomic energy, promoting the construction of professional talents in the field of atomic energy, promoting technological innovation, realizing the development of military-civilian integration, encouraging and supporting enterprises to participate in the development of the international market, and promoting exports. For details, please refer to the original draft of the the People's Republic of China Atomic Energy Law.
Wuxi Beta and Shenyang Research Institute of Chemical Industry to establish a cooperative relationship
2018-08-15
On August 15, 2018, Wuxi Beta Pharmaceutical Technology Co., Ltd. and the Safety Evaluation Center of Shenyang Research Institute of Chemical Industry signed a strategic cooperation agreement to complement each other's advantages and do their best to cooperate in the development of C14 and tritium labeling of pesticides and the pharmaceutical generation of animals and plants in China Research, actively promote China's agricultural development and environmental protection.
Wuxi Beta establishes partnership with American CIL
2018-07-18
On July 18, 2018, Wuxi Beta Pharmaceutical Technology Co., Ltd. signed a supply agreement with CambridgeIsotopeLaboratories,Inc.(CIL) to jointly develop the industrialization of isotope labeled products such as urea-13C and promote the popularization of gastric Helicobacter pylori detection in China.
Gradually realize import substitution, in vitro diagnostics industry to open a market of hundreds of billions.
2018-06-08
Translational Medicine Network 2018-06-08 Today, our "Looking for Real Growth in the Pharmaceutical Industry" series focuses on medical devices. Its largest subdivision is in vitro diagnosis. In vitro diagnosis refers to the extraction of patients' blood for testing and guiding treatment. At present, more than 70% of clinical diagnostic information comes from in vitro diagnosis, so it is also called "doctor's eyes". Let's take a look at the reporter survey. The import of medical devices relies heavily on multinational companies to monopolize the market. The West China Hospital of Sichuan University in Chengdu has to process about 18000 test specimens from all over the country every day. in the busy
● Beita News
● Industry News
● Media Coverage